IBL HealthCare Limited reported a net profit of Rs 167.49 million for the nine months ended March 31, 2026

Filed as: Financial Results for the quarter ended March 31, 2026

IBLHLIBL HealthCare LimitedIBLHL · PharmaceuticalsFinancial resultFiled Pakistan time

Summary

IBL HealthCare Limited reported a net profit of Rs 167.49 million for the nine months ended March 31, 2026, up from Rs 135.47 million in the prior period, driven by increased revenue.

Read the original filing

Figures in the filing

ItemThis periodPeriod beforeChange
Revenue3.30B3.14B+5.1%
Net Profit167.49M135.47M+23.6%
Gross Profit1.24B988.11M+25.9%
Earnings Per Share (EPS)1.701.37+24.1%
Cash and Bank Balances111.88M208.94M-46.5%

Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).

What the filing says

  • Revenue increased to Rs 3.30 billion from Rs 3.14 billion, reflecting a growth of 5.09%.
  • Net profit rose to Rs 167.49 million, a 23.64% increase from the prior period's Rs 135.47 million.
  • Gross profit improved to Rs 1.24 billion from Rs 988.11 million, indicating better cost management.

IBL HealthCare Limited (IBLHL) on Nafa

Last price Rs 41.00 · Pharmaceuticals · You can own IBLHL shares from your phone.

More IBLHL announcements

All IBLHL announcements

Source: IBL HealthCare Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.